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Using a diverse collection of small molecules generated from a
variety of sources, we measured protein-binding activities of each
individual compound against each of 100 diverse (sequence-unre-
lated) proteins using small-molecule microarrays. We also analyzed
structural features, including complexity, of the small molecules.
We found that compounds from different sources (commercial, aca-
demic, natural) have different protein-binding behaviors and that
these behaviors correlate with general trends in stereochemical
and shape descriptors for these compound collections. Increasing
the content of sp3-hybridized and stereogenic atoms relative to
compounds from commercial sources, which comprise the majority
of current screening collections, improved binding selectivity and
frequency. The results suggest structural features that synthetic
chemists can target when synthesizing screening collections for
biological discovery. Because binding proteins selectively can be
a key feature of high-value probes and drugs, synthesizing com-
pounds having features identified in this study may result in
improved performance of screening collections.
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Small-molecule probe- and drug-discovery activities in acade-mia and the pharmaceutical industry often begin with high-
throughput screening. Many thousands of small molecules are
tested with the expectation that each has potential as a discovery
lead. Thus, assembling or synthesizing compound collections for
small-molecule screening represents an important step in discov-
ery success, particularly when selecting among compounds from a
variety of synthetic and natural sources. Unbiased methods to
evaluate the assay performance of compounds from different
sources, and to relate performance to chemical structure (defined
by computed structural properties) (1, 2), can provide guidance
to one element of more valuable small-molecule screening
collections.
Comparative analyses between compounds often involve che-
minformatic analysis of compound structures (3–5) or retrospec-
tive analysis of compound performance by mining the literature
(6–8) or historical data (9, 10). For example, intermediate mole-
cular complexity has been suggested as theoretically preferable
for drug leads (11), and this relationship is supported by evidence
mined from historical data (9). In this study, we performed un-
biased comparisons of compounds from natural and synthetic
sources by first identifying compounds with unknown activities
and then exposing them to a common assay platform. We iden-
tified a compound collection comprising three subsets: (i) 6,152
compounds from commercial sources that are representative of
many common screening collections (commercial compounds;
CC); (ii) 6,623 compounds assembled from the academic syn-
thetic chemistry community using, e.g., diversity-oriented synth-
esis (diverse compounds; DC); and (iii) 2,477 naturally occurring
compounds (natural products; NP). We then (i) analyzed distri-
butions of stereochemical and shape complexity for each set;
(ii) measured protein-binding activities of each member against
each of 100 diverse proteins using small-molecule microarrays
(SMMs) (12, 13); and (iii) correlated these computed and
measured properties (Fig. 1). The resulting correlations suggest
that structural features of small molecules relating to hybridiza-
tion and stereochemistry are important contributors to binding
proteins selectively.
Results
To quantify stereochemical and shape complexity, we calculated
two parameters for each compound for comparative analysis be-
tween the three compound sources. While it is likely that more
complex descriptors may better physically model molecular shape
complexity, one motivation of the current study was to link simple
size-independent metrics with compound performance. First, we
defined stereochemical complexity as the proportion of carbon
atoms that are stereogenic (Cstereogenic∕Ctotal). This metric pro-
vides a size-independent global assessment of stereochemical
complexity, varying on the range [0,1] for each molecule. Inspect-
ing histograms of this metric as a function of compound source
(Fig. 2) revealed that CC is lowest in stereochemical complexity
(median ¼ 0.00; mean ¼ 0.022). In contrast, NP is highest in
stereochemical complexity (median ¼ 0.24; mean ¼ 0.24), while
DC has intermediate values (median ¼ 0.11; mean ¼ 0.12).
Second, we defined shape complexity as the ratio of sp3-hybri-
dized carbon atoms to total sp3- and sp2-hybridized carbons
(Csp3∕½Csp2 þ Csp3). This metric is similar to the recently reported
Fsp3 metric (14); again, this metric is size-independent, varying
on the range [0,1] for each molecule. Using this metric (Fig. 3A),
we observed that CC is lowest in proportion of sp3-hybridized
carbons (median ¼ 0.22; mean ¼ 0.27), NP is highest (median ¼
0.55; mean ¼ 0.55), and DC has an intermediate distribution
(median ¼ 0.36; mean ¼ 0.39). When we restricted our analysis
to carbon atoms in the molecular scaffold (15), we observed a
decrease in overall sp3 carbon proportions in all three popula-
tions (Fig. 3B). This effect was most striking in CC (median ¼
0.071; mean ¼ 0.16), indicating that a substantial portion of
sp3 carbons in these molecules are in appendages rather than
in (predominantly flat) core skeletons. In contrast, NP molecules
retain a large proportion of their sp3 carbons in core skeletons
(median ¼ 0.50; mean ¼ 0.49).
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In addition to analyzing computed properties, we sought to
determine differences in protein-binding abilities of compounds
from different origins. For this study, we analyzed a dataset re-
sulting from testing all members of the compound collection in-
dividually in binding assays against each of 100 different purified
proteins using the SMM platform, which gives a preliminary
indication of protein binding. In terms of sequence, proteins were
selected having a wide range of structural types rather than re-
presenting a family or families of proteins. In terms of function,
the proteins were selected having varying roles in transcriptional
regulation. SMM slides were exposed in triplicate to each of 100
purified proteins in independent experiments and to a common
epitope tag as a control. For the present study, we scored as “hits”
for each protein those compounds whose average deviation from
control-spot intensities exceeded a fixed threshold for statistical
significance, after correction for multiple hypothesis testing (see
Materials and Methods). We also eliminated compounds that
bound the antibody to the control epitope tag, because these
events likely do not correspond to specific binding to the 100 pa-
nel proteins. These experiments resulted in a matrix of binary hit
calls for 15,252 compounds versus 100 proteins, of which 3,433
(22.5%) compounds bound at least one protein (Fig. 4). We note
that this high fraction of compounds binding any protein is not
unexpected with 100 parallel protein-binding assays; for example,
if hit rates were 0.5% for each protein, and hit compounds were
selected randomly for each of 100 proteins, we would expect
1 − ð0.995Þ100 ≈39% of compounds to bind at least one protein.
We characterized the resulting 100 protein-binding profiles
for each of CC, DC, and NP subsets using two measures of per-
formance that inform how useful a small-molecule collection
might be to the screening community: (i) a measure of the rate
at which hits were identified from each subset, and (ii) a measure
of specificity of the discovered hits from each subset, based on
the number of proteins bound by a given hit. First, we examined
the propensity of compounds from different sources to score
positive in any protein-binding assay. A smaller proportion of
NP compounds (13%; 324) were called a hit in any assay than
were CC (23%; 1,415) or DC (26%; 1,694) compounds. To deter-
mine whether compounds from different sources afford different
hit rates in protein-binding assays, we calculated 100 separate hit
rates (one per protein) for compounds from each source. Analysis
of these hit-rate distributions (Fig. 5) revealed that median hit
rates are highest, and distribution least disperse, for DC. Median
hit rates were intermediate for CC but with more dispersion in
Fig. 1. Study design to relate structural complexity to protein-binding profiles. Three sources of compounds were studied; diverse samples of each subset are
shown to illustrate differences between the subsets (all structures in the study are presented in Dataset S1 and Dataset S2).
Fig. 2. Stereochemical complexity of compounds from three sources. Com-
plexity is expressed as the proportion of all carbon atoms that are stereogenic
carbon atoms (Cstereogenic∕Ctotal).
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their values. Median hit rates were lowest for NP, with only 7 of
100 rates for NP exceeding those in the lowest quartile for DC.
Thus, compounds from different sources exhibit different group-
wide behavior in protein-binding experiments, using the proteins
included in this study.
This first analysis considered any binding event in establishing
hit rates. To compare the binding specificity for compounds from
each source, we determined the relative proportions of both
highly promiscuous and highly specific compounds. To evaluate
highly promiscuous compounds (Fig. 6A), we determined the
relative proportion of hit compounds binding 1–5 proteins
(specific), 6–24 proteins (promiscuous), or 25+ proteins (highly
promiscuous). Both CC and DC harbor significantly enriched
proportions of compounds that were either promiscuous (CC;
16%) or highly promiscuous (DC; 3.1%) in binding profiles. Be-
cause the synthetic pathways for DC were well-defined, we were
able to categorize most (74.7%) of the 1,160 hit compounds as
having come from one of 21 distinct synthetic chemistry pathways
each having at least 20 members in DC (the remainder were
either individual submissions or only identified by the contribut-
ing laboratory, rather than by a specific synthesis pathway).
To determine whether binding promiscuity in DC could be
traced to a relatively small number of similar compounds, we
tested whether the distributions of numbers of bound proteins
for each of these 21 pathways could be distinguished from DC
at large. We identified a single pathway, based on a spiroxindole
skeleton (16), that was dramatically enriched (p < 1.6 × 10−12
using a Kolmogorov–Smirnov test (17) between its members
and the rest of DC) in the number of proteins to which its mem-
bers bound (mean ¼ 11.4 proteins vs. mean ¼ 2.4 proteins for the
rest ofDC). This insight allowed us to reanalyze promiscuity using
a DC subset, termed DC0, lacking the 660 compounds derived
from this synthetic pathway (of which 288 were hit compounds,
the right-most 288 columns in Fig. 4). Using DC0 rather than DC
in the overall comparison (Fig. 6B), we observed that only CC
remained significantly enriched in promiscuous compounds
and contained fewer specific members (82%) than expected by
chance (i.e., if promiscuous compounds were spread across
CC, DC0, and NP in proportion to the size of each group), given
the lower total number of compounds. In contrast, DC (6.3%),
DC0 (5.3%), and NP (2.5%) all contained proportions of promis-
cuous compounds lower than expected by chance (again relative
to proportional representation). All other observations could be
explained by statistical expectation, based on overall proportions
across all three sources. This ability to identify and to eliminate
problematic outliers derived from a specific synthetic pathway in
DC should be useful in efforts to create optimally diverse and
specific small-molecule screening collections.
To rule out whether cryptic groups of related structures might
similarly explain promiscuity within CC (analogous to the spirox-
indoles removed from DC), we compared Tanimoto fingerprint
similarities (unfolded ECFP_4) (18, 19) among the most promis-
cuous members of CC to those of the entire CC group and found
them to be very similar (0.109 vs. 0.112 average similarity, indi-
cating slightly more self-similarity among CC as a whole than
among the most promiscuous members). We also checked the
251 most promiscuous members of CC for substructures common
to at least 10% of the members and found nothing larger than an
N-benzylethylamine substructure (27 instances, or 10.8%, com-
pared with 11.7% occurrence in all of CC) in common among
these compounds. These tests suggest that, in contrast to DC,
the tendency to promiscuity among CC members is distributed
over a large number of “chemotypes.”
We also examined the distribution of hit specificities in the CC,
DC0, and NP subsets (Fig. 7). We determined the relative propor-
tion of hit compounds binding exactly one protein (highly
specific), 2–5 proteins (partially specific), or 6+ proteins (promis-
cuous). These groupings parallel those in our promiscuity analy-
Fig. 3. Shape complexity of compounds from three sources. Complexity is
expressed as the proportion of sp2- or sp3-hybridized carbon atoms that
are sp3-hybridized (Csp3∕½Csp2 þ Csp3); (A) whole molecules, (B) “scaffold”
atoms in the molecular framework only.
Fig. 4. Binary hit calls for compounds from three sources against 100 proteins. Heatmap depicts presence (white) or absence (black) of a hit call for all
compounds scoring as hits against at least one protein. Colored bars indicate source of compounds: CC (red), NP (green), DC (blue).
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sis, merging the two promiscuous groups into a single category
and splitting the specific group into two categories. We found that
CC harbors significantly enriched proportions of partially specific
(28%) and promiscuous (18%) compounds and is depleted in
highly specific (54%) compounds. In contrast, both DC0 (73%)
and NP (83%) are significantly enriched in highly specific com-
pounds, with a corresponding depletion (DC0: 6.3%;NP: 2.5%) of
promiscuous compounds. Further, NP is depleted even of par-
tially specific compounds (15%). Across all specificity categories,
only the proportion of partially specific DC0 members was con-
sistent with overall proportions across all three sources.
Finally, we determined whether binding trends could be
connected directly with computed properties, irrespective of
compound source. We categorized all 15,252 compounds into
three categories of stereochemical complexity (using Cstereogenic∕
Ctotal), restricting our analysis to carbons in the molecular scaf-
fold (cf., Fig. 2B): stereochemically simple (Cstereogenic∕Ctotal ¼ 0),
intermediate (0 < Cstereogenic∕Ctotal ≤ 0.25), and complex
(Cstereogenic∕Ctotal > 0.25) molecules (Fig. 8). We observed that
stereochemically simple molecules are significantly enriched in
binders to 2+ proteins (9.5%), and stereochemically complex
molecules are depleted for such binders (3.5%). The stereoche-
mically complex category is also depleted for compounds binding
any protein, consistent with our finding thatNP has both the high-
est stereochemical complexity and the lowest overall hit rates.
Most interestingly, compounds with intermediate stereochemical
complexity, regardless of source, are enriched in binders to ex-
actly 1 of 100 tested proteins (15.7%) and depleted of compounds
that bind 6+ proteins (1.7%). To verify that these results were
not significantly skewed by false negatives, i.e., small molecules
lacking a functional group known to print effectively on SMMs
(20), we confirmed that there were no significant differences in
proportions among promiscuity categories between compounds
having or lacking such functional groups.
Discussion
Viewed globally, approximately 15,000 compounds from three
different sources have strikingly different behaviors when tested
individually for their ability to bind members of a large collection
of sequence-unrelated proteins. The subcollections of com-
pounds tested here are unbiased, because they were assembled
without prior knowledge of the properties or assay performances
of their members, although we note that the choices otherwise
were made largely for practical reasons, namely availability in
our overall screening collection in formats amenable to SMM
production.
We observed general trends among stereochemical and shape
descriptions of these compound collections. Both protein-binding
frequencies and selectivities are increased among compounds
having: (i) increased content of sp3-hybridized atoms relative
to commercial compounds, and (ii) intermediate frequency of
stereogenic elements relative to commercial (low frequency)
and natural (high frequency) compounds. Encouragingly, these
favorable structural features are increasingly accessible using
modern advances in the methods of organic synthesis (21–26)
and commonly targeted by academic organic chemists as judged
by the compounds used in this study that were contributed by
Fig. 5. Hit-rate analysis of compounds from three sources in 100 protein-
binding assays. Box-whisker plots depict second and third quartiles (blue
boxes) above and below median values (red lines) with adjacent values indi-
cating maximum nonoutlier values (black whiskers) and outlier values (red
crosses); see legend at right. These data show the greatest hit rates for
DC and lowest for NP (see text).
Fig. 6. Analysis of binding promiscuity among hit compounds. Three promis-
cuity categories were evaluated for compounds scored as hits against at least
one protein in 100 protein-binding assays: binding to 1–5 proteins (white),
6–24 proteins (gray), 25+ proteins (black); numbers of compounds with
significant enrichment (**) or depletion (*), relative to the overall proportion
(far left), are indicated. These data show (A) CC members are most likely to
bind 6+ proteins, NP members least likely, and DC members intermediate;
(B) reevaluation after removing spiroxindole-based compounds derived from
one synthetic pathway in DC to create DC0 (see text) suggests that much pro-
miscuous binding among DC can be attributed to a single class of compound.
Fig. 7. Analysis of binding specificity among hit compounds. Three specifi-
city categories were evaluated for compounds scored as hits against at least
one protein in 100 protein-binding assays: binding to exactly one protein
(white), 2–5 proteins (gray), 6+ proteins (black); numbers of compounds in-
dicating significant enrichment (**) or depletion (*), relative to the overall
proportion (far left), are indicated. These data show both DC0 and NP mem-
bers are most likely to bind exactly one protein, while significant fractions of
CC members bind at least two proteins (see text).
Fig. 8. Connection between binding specificity and stereochemical
complexity. Four specificity categories (including non-hits) were evaluated:
binding to 0 proteins (light gray), exactly 1 protein (white), 2–5 proteins
(gray), 6+ proteins (black); numbers of compounds indicating significant
enrichment (**) or depletion (*) relative to proportional representation
are indicated. These data show stereochemically simple compounds most
likely bindmultiple proteins, intermediate complexity compounds most likely
bind exactly 1 protein, and the most complex compounds most likely bind 0
proteins (see text).
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members of this community. On the other hand, these features
are notably deficient in members of compound collections cur-
rently widely used in probe- and drug-discovery efforts.
The choice of our simple stereochemical complexity descriptor
for correlation with binding data reflects the motivation of the
current study to link simple size-independent metrics and perfor-
mance. In future studies, we will aim to test more systematically
whether other descriptors, features, or physicochemical proper-
ties might be quantitatively related to such performance metrics,
e.g., as judged by multivariate regression analysis. Future studies
might also be more deliberate about choosing either structurally
representative or diverse subsets from larger compound collec-
tions. Similarly, larger samples of compounds, different proteins,
and different assay formats, especially cell-based ones, will be
required to establish the generality of our conclusions.
The ability of small molecules to bind proteins selectively is
just one factor that determines their value as leads in probe-
and drug-discovery efforts. Not examined in this study are their
ability to modulate protein functions in cells and organisms and
their ease of optimization using organic synthesis. Nevertheless,
these results already cast some doubt on the wisdom of the com-
mon heavy reliance on sp2-rich commercial compounds in small-
molecule screening efforts. In preliminary analyses to be and
recently reported elsewhere, additional differences have been
identified in cellular assay contexts on the one hand and relative
to natural selection (27) on the other. In the future, measuring
the facility of optimizing compounds having different origins will
be useful to guide even more valuable screening collections. The
studies reported here constitute one step toward the goal of quan-
tifying the biological performance of compounds from different
origins and having different computed structural properties,
assisting in distinguishing fact from intuition.
Materials and Methods
Compound Collections. Small molecules in CC were obtained from ChemDiv
(www.chemdiv.com/), Maybridge (www.maybridge.com/), and TimTec
(www.timtec.com/). Small molecules in DC were obtained from several
academic laboratories, including member laboratories of the NIGMS
Centers of Excellence in Chemical Methodology and Library Development
(www.nigms.nih.gov/Initiatives/CMLD/). Small molecules inNPwere obtained
from Analyticon (www.ac-discovery.com/). In all cases, compounds were
maintained by the Broad Institute compound management group prior to
their use in the experiments described. Dataset S1 contains: a table (“com-
pounds”) listing the simplified molecular input line entry specification
(SMILES) (28, 29) representation of each compound used in this study; a table
(“descriptors”) indicating the category (CC, DC, or NP), structure descriptors,
and ChemBank (30) names for each compound; a table (“proteins”) listing
the proteins used in this study; and a table (“CpdsXProteins”) of binary
hit calls for all measurements. ChemBank names identify commercial sources
and can be used to obtain additional information about the compounds
from either ChemBank (http://chembank.broadinstitute.org) or PubChem
(http://pubchem.ncbi.nlm.nih.gov). Dataset S2 contains an alternative repre-
sentation of all compound structures in SDF file format.
Small-Molecule Microarrays. Each compound in the study was printed on glass
microscope slides according to published SMM protocols (13). In silico func-
tional group analysis of compounds study revealed that 76.8% of the com-
pounds contain at least one functional group previously shown to undergo
covalent attachment to SMMs (20) using an isocyanate surface-attachment
chemistry, such as alcohols, phenols, acids, thiols, and amines. The remaining
compounds may print covalently through groups not previously tested or
may simply adsorb noncovalently. Proteins spanning 145 InterPro domain
classifications (www.ebi.ac.uk/interpro/) were obtained commercially as
His6 epitope-tagged reagents for rapid identification using fluorophore-
conjugated anti-His6 antibodies. Importantly, many of these proteins were
explicitly tested in appropriate functional assays to ensure that they were
properly folded, and all SMM experiments were performed under conditions
that were developed to be compatible with protein function. Complete de-
tails of these binding assays, including SMM printing, protein-binding, wash
conditions, image analysis, scoring methods, confirmatory experiments, and
functional studies of hit compounds, will be described elsewhere. Dataset S1
contains a table listing the complete set of protein names used in this study,
each as approved names or aliases recognized by the HUGO Gene Nomen-
clature Committee (http://www.genenames.org/index.html).
Data Analysis. SMM slides were scanned by a GenePix scanner (Molecular
Devices), and each SMM spot intensity was scored by its deviation from a
population of vehicle-control spots on the same slide. Three replicate mea-
surements were combined as weighted averages of deviations, normalized
by the variance of corresponding vehicle-control distributions and measure-
ment uncertainties. We called a positive hit any compound whose normal-
ized score for protein binding exceeded the expected score for the most
extreme acceptable vehicle-control outlier at a fixed statistical significance
(familywise error rate p < 0.05 by Holm–Bonferroni method) (31), indicating
a greater likelihood that the compound was a member of a putative hit dis-
tribution than of the vehicle-control distribution. To ensure that hit calls were
not influenced by subset-specific differences in functional groups predicted
to print covalently, we compared the overall hit rates for the sets of com-
pounds either lacking or having known-printable functional groups (20)
and found these rates essentially unchanged for all three subsets (23.3%
vs. 22.8% for CC, 24.7% vs. 25.7% for DC, 13.7% vs. 13.0% for NP). ECFP4
fingerprints, molecular scaffolds, molecular property counts, and derived
descriptors were computed using Pipeline Pilot (Accelrys, Inc.). Statistical ana-
lyses, visualizations of distributions, and all Results figures were prepared in
MATLAB (The MathWorks, Inc.). Significance of enrichment or depletion of
compound groups in either promiscuity or specificity groups was determined
using the chi-squared test for homogeneity, with individual enrichment/de-
pletion assignments by the method of normalized residuals (32). Dataset S1
contains a table listing the complete binary (15;252 × 100) hit calls used in the
analysis.
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